THE Alliance could start without Hanjin

Xiaolin Zeng

首页> 外文期刊>Fairplay International Shipping Weekly >THE Alliance could start without Hanjin

【24h】

THE Alliance could start without Hanjin

机译：没有韩进，联盟就可以开始

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

With the future of Hanjin Shipping looking uncertain since South Korea's largest shipping line went into receivership on 1 September, the group could be expelled from a box shipping alliance that is to begin operating in April 2017. NYK Line chairman Yasumi Kudo, who is also chairman of the Japanese Shipowners' Association, told reporters that it would be "impossible" for THE Alliance's Japanese member lines to work with Hanjin.

机译：自从韩国最大的航运公司于9月1日进入接管船以来，韩进海运的未来似乎不确定，该集团有可能从一个将于2017年4月开始运营的盒装航运联盟中解散。日本船东协会的负责人告诉记者，THE Alliance的日本会员行与Hanjin合作是“不可能的”。

著录项

来源
《Fairplay International Shipping Weekly》 |2016年第6890期|20-20|共1页
作者
Xiaolin Zeng;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Hanjin Steel Pipes to Start Up No.2 Plant in December [J] . The Korea Metal Journal . 2011,第11a15期

机译：韩进钢管将于12月启动第二工厂
2. ALLIANCES DE COMPÉTENCES ENTRE MAJORS ET START-UPS [J] . Cahiers techniques du batiment . 2018,第367期

机译：主要与初创企业之间的技能联盟
3. Strategic Alliances Create Path to Commercialization for a Microalgae-Focused Start-Up [J] . Adelheid (Heidi) Kuehnle, Mark Ritchie Industrial Biotechnology . 2013,第5期

机译：战略联盟为针对微藻类的初创企业开辟了商业化道路
4. Patent strategy in exploration and exploitation alliances: The case of biotechnology start-ups [C] . Wang Bo, Subramanian Annapoornima M., Chai Kah-Hin Portland International Center for Management of Engineering and Technology . 2015

机译：勘探与开发联盟的专利战略：生物技术初创企业案例
5. The impact of firm capability on interfirm alliances: An analysis of United States semiconductor start-up firms. [D] . Chen, Rongxin. 1996

机译：企业能力对企业间联盟的影响：对美国半导体初创企业的分析。
6. Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized Double-Blind Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance) [O] . Harold J. Burstein, Constance T. Cirrincione, William T. Barry, -1

机译：有或没有抑制表皮生长因子受体和人表皮生长因子受体的内分泌治疗2：接受或不接受拉帕替尼的氟维沙坦的随机双盲安慰剂对照的Ⅲ期临床试验用于绝经后激素受体阳性的晚期乳腺癌女性。 CALGB 40302（联盟）
7. How software start-ups can leverage alliances, acquisitions, IPOs and venture capital [O] . Ybanez Sergio D 2007

机译：软件初创企业如何利用联盟，收购，IpO和风险投资

THE Alliance could start without Hanjin

摘要

著录项

相似文献

相关主题

期刊订阅